Domainex appoints Dr Trevor Perrior as Chief Executive Officer
Following his education at the University of Cambridge, Dr Perrior undertook academic research at Cambridge, Oxford and in the USA. He then held senior R&D roles in pharmaceutical and biotechnology companies ICI, Zeneca, AstraZeneca and Celltech, where he worked on sites in the UK, USA and Switzerland. Dr Perrior is also a scientific consultant to a number of venture capital and charitable organisations and is the Visiting Professor of Medicinal Chemistry at The University of Sussex.
Most read news
Other news from the department people
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.